Have a personal or library account? Click to login
The GABA Hypothesis in Essential Tremor: Lights and Shadows Cover

The GABA Hypothesis in Essential Tremor: Lights and Shadows

Tremor and Other Hyperkinetic Movements
Volume 4 (2014): Issue 0
By: Alexandre Gironell  
Open Access
|Jul 2014

References

  1. 1
    LouisEDEssential tremorLancet Neurol200541001010.1016/S1474-4422(05)00991-915664542
    Back to article
  2. 2
    DeuschlGRaethjenJHellriegelHElbleRTreatment of patients with essential tremorLancet Neurol20111014816110.1016/S1474-4422(10)70322-721256454
    Back to article
  3. 3
    LouisEDA new twist for stopping the shakes? Revisiting GABAergic therapy for essential tremorArch Neurol19995680780810.1001/archneur.56.7.80710404981
    Back to article
  4. 4
    DupuisMJDelwaidePJBoucqueyDGonsetteREHomolateral disappearance of essential tremor after cerebellar strokeMov Disord1989418318710.1002/mds.8700402102733709
    Back to article
  5. 5
    DuncanRBoneIMelvilleIDEssential tremor cured by infarction adjacent to the thalamusJ Neurol Neurosurg Psychiatry19885159159210.1136/jnnp.51.4.5913379439
    Back to article
  6. 6
    PahwaRLyonsKEWilkinsonSBet alLong-term evaluation of deep brain stimulation of the thalamusJ Neurosurg200610450651210.3171/jns.2006.104.4.50616619653
    Back to article
  7. 7
    GironellAKulisevskyJLorenzoJBarbanojMPascual-SedanoBOterminPTranscranial magnetic stimulation of the cerebellum in essential tremor: A controlled studyArch Neurol20025941341710.1001/archneur.59.3.41311890845
    Back to article
  8. 8
    PopaTRussoMVidailhetMet alCerebellar rTMS stimulation may induce prolonged clinical benefits in essential tremor, and subjacent changes in functional connectivity: An open label trialBrain Stimul2013617517910.1016/j.brs.2012.04.00922609238
    Back to article
  9. 9
    ColebatchJGFindleyLJFrackowiakRSMarsdenCDBrooksDJPreliminary report: Activation of the cerebellum in essential tremorLancet19903361028103010.1016/0140-6736(90)92489-51977019
    Back to article
  10. 10
    WillsAJJenkinsIHThompsonPDFindleyLJBrooksDJRed nuclear and cerebellar but no olivary activation associated with essential tremor: A positron emission tomographic studyAnn Neurol19943663664210.1002/ana.4103604137944296
    Back to article
  11. 11
    HallettMDubinskyRMGlucose metabolism in the brain of patients with essential tremorJ Neurol Sci1993114454810.1016/0022-510X(93)90047-38433096
    Back to article
  12. 12
    LouisEDShunguDCChanSMaoXJurewiczECWatnerDMetabolic abnormality in the cerebellum in patients with essential tremor: A proton magnetic resonance spectroscopic imaging studyNeurosci Lett2002333172010.1016/S0304-3940(02)00966-712401550
    Back to article
  13. 13
    LouisEDShunguDCMaoXChanSJurewiczECCerebellar metabolic symmetry in essential tremor studied with 1H magnetic resonance spectroscopic imaging: Implications for disease pathologyMov Disord20041967267710.1002/mds.2001915197706
    Back to article
  14. 14
    DanielsCPellerMWolffSet alVoxel-based morphometry shows no decreases in cerebellar gray matter volume in essential tremorNeurology2006671452145610.1212/01.wnl.0000240130.94408.9917060572
    Back to article
  15. 15
    LouisEDFaustPLVonsattelJPet alNeuropathological changes in essential tremor: 33 cases compared with 21 controlsBrain2007130329730710.1093/brain/awm26618025031
    Back to article
  16. 16
    AxelradJELouisEDHoningLSet alReduced Purkinje cell number in essential tremor: A post-mortem studyArch Neurol20086510110718195146
    Back to article
  17. 17
    LouisEDFaustPLVonsattelJPPurkinje cell loss is a characteristic of essential tremor: Towards a more mature understanding of pathogenesisParkinsonism Relat Disord2012181003100410.1016/j.parkreldis.2012.06.01722795481
    Back to article
  18. 18
    LouisEDBabijRLeeMCortesEVonsattelJPQuantification of cerebellar hemispheric Purkinje cell linear density: 32 ET cases versus 16 controlsMov Disord2013281854910.1002/mds.2562923925732
    Back to article
  19. 19
    BoweryNGBettlerBFroestlWet alInternational union of pharmacology. XXXIII. Mammalian gamma-aminobutyric acid(B) receptors: Structure and functionPharmacol Rev20025424726410.1124/pr.54.2.24712037141
    Back to article
  20. 20
    MouginotDGahwilerBHPresynaptic GABAB receptors modulate IPSPs evoked in neurons of deep cerebellar nuclei in vitroJ Neurophysiol1996758949018714662
    Back to article
  21. 21
    MallyJBaranyiMViziESChange in the concentrations of amino acids in CSF and serum of patients with essential tremorJ Neural Transm199610355556010.1007/BF012731538811501
    Back to article
  22. 22
    Paris-RobidasABrochuESintesMet alDefective dentate nucleus GABA receptors in essential tremorBrain201213510511610.1093/brain/awr30122120148
    Back to article
  23. 23
    ShillHAAdlerCHBeachTGet alBrain biochemistry in autopsied patients with essential tremorMov Disord20122711311710.1002/mds.2400422038525
    Back to article
  24. 24
    UusisaariMKnopfelTGABAergic synaptic communication in the GABAergic and non-GABAergic cells in the deep cerebellar nucleiNeuroscience200815653754910.1016/j.neuroscience.2008.07.06018755250
    Back to article
  25. 25
    JahnsenHExtracellular activation and membrane conductances of neurones in the guinea-pig deep cerebellar nuclei in vitroJ Physiol19863721491682425083
    Back to article
  26. 26
    LlinasRRThe intrinsic electrophysiological properties of mammalian neurons: Insights into central nervous system functionScience19882421654166410.1126/science.30594973059497
    Back to article
  27. 27
    LlinasRMuhlethalerMElectrophysiology of guinea-pig cerebellar nuclear cells in the in vitro brain stem-cerebellar preparationJ Physiol19884042412582855348
    Back to article
  28. 28
    PinaultDDeschenesMThe origin of rhythmic fast subthreshold depolarizations in thalamic relay cells of rats under urethane anaesthesiaBrain Res199259529530010.1016/0006-8993(92)91063-K1467972
    Back to article
  29. 29
    DengHXieWJLeWDHuangMSJankovicJGenetic analysis of the GABRA1 gene in patients with essential tremorNeurosci Lett2006401161910.1016/j.neulet.2006.02.06616530959
    Back to article
  30. 30
    ThierSKuhlenbäumerGLorenzDet alGABA(A) receptor and GABA transporter polymorphisms and risk for essential tremorEur J Neurol201181098110010.1111/j.1468-1331.2010.03308.x21749575
    Back to article
  31. 31
    García-MartinEMartínezCAlonso-NavarroHet alGamma-aminobutyric acid GABRA4, GABRE, and GABRQ receptor polymorphisms and risk for essential tremorPahrmacogenet Genomics2011743643910.1097/FPC.0b013e328345bec0
    Back to article
  32. 32
    García-MartinEMartínezCAlonso-NavarroHet alGamma-aminobutyric acid (GABA) receptor rho (GABRR) polymorphisms and risk for essential tremorJ Neurol2011220321110.1007/s00415-010-5708-z20820800
    Back to article
  33. 33
    KuhlenbäumerGHopfnerFDeuschlGGenetics of essential tremor: Meta-analysis and reviewNeurology2014821000100710.1212/WNL.000000000000021124532269
    Back to article
  34. 34
    KralicJECriswellHEOstermanJLet alGenetic essential tremor in gamma-aminobutyric acidA receptor alpha1 subunit knockout miceJ Clin Invest200511577477910.1172/JCI20052362515765150
    Back to article
  35. 35
    BoeckerHWeindlABrooksDJet alGABAergic dysfunction in essential tremor: An 11C-Flumazenil PET studyJ Nucl Med2010511030103510.2967/jnumed.109.07412020554735
    Back to article
  36. 36
    GironellAFigueirasFPPagonabarragaJHeranceJRPascual-SedanoBTrampalCGispertJDGaba and serotonin molecular neuroimaging in essential tremor: A clinical correlation studyParkinsonism Relat Disord20121887688010.1016/j.parkreldis.2012.04.02422595620
    Back to article
  37. 37
    MondrupKDupontEPedersonEThe effect of the GABA-agonist, progabide, on benign essential tremorActa Neurol Scand19836824825210.1111/j.1600-0404.1983.tb04833.x6362317
    Back to article
  38. 38
    KollerWCRubinoFGuptaSPharmacologic probe with progabide of GABA mechanisms in essential tremorArch Neurol19874490590610.1001/archneur.1987.005202100070093619708
    Back to article
  39. 39
    MallyJStoneTThe effect of theophylline on essential tremor: The possible role of GABAPharmacol Biochem Behav19913934534910.1016/0091-3057(91)90190-D1946576
    Back to article
  40. 40
    PahapillPALevyRDostrovskyJOet alTremor arrest with thalamic microinjections of muscimol in patients with essential tremorAnn Neurol19994624925210.1002/1531-8249(199908)46:2<;249::AID-ANA15>3.0.CO;2-C10443891
    Back to article
  41. 41
    GironellAKulisevskyJBarbanojMLópez-VillegasDHernándezGPascual-SedanoBA randomized placebo-controlled comparative trial of gabapentin and propranolol in essential tremorArch Neurol19995647548010.1001/archneur.56.4.47510199338
    Back to article
  42. 42
    PahwaRLyonsKHubbleJPBusenbarkKRienerthJDDouble-blind controlled trial of gabapentin in essential tremorMov Disord19981346546710.1002/mds.8701303159613738
    Back to article
  43. 43
    OndoWHunterCDat WuongKScwartzKJankovicJGabapentin for essential tremor: A multiple-dose, double-blind placebo-controlled trialMov Disord20001567868210.1002/1531-8257(200007)15:4<;678::AID-MDS1012>3.0.CO;2-010928578
    Back to article
  44. 44
    ZesiewiczTAElbleRJLouisEDet alEvidence-based guideline update: Treatment of essential tremor: Report of the Quality Standards subcommittee of the American Academy of NeurologyNeurology2011171752175510.1212/WNL.0b013e318236f0fd22013182
    Back to article
  45. 45
    ConnorGSA double-blind placebo-controlled trial of topiramate treatment for essential tremorNeurology20025913213410.1212/WNL.59.1.13212105323
    Back to article
  46. 46
    OndoWGJankovicJConnorGSet alTopiramate in essential tremor: A double-blind, placebo-controlled trialNeurology20066667267710.1212/01.wnl.0000200779.03748.0f16436648
    Back to article
  47. 47
    FrimaNGrünewaldRAA double-blind, placebo-controlled, crossover trial of topiramate in essential tremorClin Neuropharmacol20062949610.1097/00002826-200603000-0000716614542
    Back to article
  48. 48
    ConnorGSEdwuardsKTarsyDTopiramate in essential tremor: Findings from double-blind, placebo-controlled, crossover trialsClin Neuropharmacol2008319710310.1097/WNF.0b013e3180d0996918382182
    Back to article
  49. 49
    GironellAMartínez-CorralMPagonabarragaXKulisevskyJTiagabine for essential tremor: An open-label trialMov Disord2008231955195610.1002/mds.2209418759354
    Back to article
  50. 50
    ZesiewiczTAWardCLHauserRAet alA pilot, double-blind, placebo-controlled trial of pregabalin in the treatment of essential tremorMov Disord2007221660166310.1002/mds.2162917580330
    Back to article
  51. 51
    FerraraJMKenneyCDavidsonALShinawiLKisselAMJankovicJEfficacy and tolerability of pregabalin in essential tremor: A randomized, double-blind, placebo-controlled, crossover trialJ Neurol Sci200928519519710.1016/j.jns.2009.06.04419631949
    Back to article
  52. 52
    ZesiewiczTASullivanKLHinsonVet alMultisite, double-blind, randomized, controlled study of pregabalin for essential tremorMov Disord20132824925010.1002/mds.2526423238907
    Back to article
  53. 53
    KollerWCVetere-OverfieldBAcute and chronic effects of propranolol and primidone in essential tremorNeurology1989391587158810.1212/WNL.39.12.15872586774
    Back to article
  54. 54
    ChakrabartiAPearceJMSEssential tremor: Response to primidoneJ Neurol Neurosurg Psychiatry19814465010.1136/jnnp.44.7.6507288456
    Back to article
  55. 55
    HuberSJPaulsonGWEfficacy of alprazolam for essential tremorNeurology19883824124310.1212/WNL.38.2.2413340287
    Back to article
  56. 56
    MantoMLauteMAA possible mechanism for the beneficial effect of ethanol in essential tremorEur J Neurol20081569770510.1111/j.1468-1331.2008.02150.x18445025
    Back to article
  57. 57
    CleevesLFindleyLJPropranolol and propranolol-LA in essential tremor: A double blind comparative studyJ Neurol Neurosurg Psychiatry19885137938410.1136/jnnp.51.3.3793283296
    Back to article
  58. 58
    LouisEDEssential tremors: A family of neurodegenerative disorders?Arch Neurol2009661202120819822775
    Back to article
  59. 59
    HuaSELenzFAZirhTAReichSGDoughertyPMThalamic neuronal activity correlated with essential tremorJ Neurol Neurosurg Psychiatry19986427327610.1136/jnnp.64.2.2739489548
    Back to article
  60. 60
    PintoADLangAEChenRThe cerebellothalamocortical pathway in essential tremorNeurology2003601985198710.1212/01.WNL.0000065890.75790.2912821747
    Back to article
  61. 61
    RajputARobinsonCARajputAHEssential tremor course and disability: A clinicopathologic study of 20 casesNeurology20046293293610.1212/01.WNL.0000115145.18830.1A15037695
    Back to article
  62. 62
    ShillHAAdlerCHSabbaghMNet alPathologic findings in prospectively ascertained essential tremor subjectsNeurology2008701452145510.1212/01.wnl.0000310425.76205.0218413570
    Back to article
  63. 63
    SymanskiCShillHADuggerBet alEssential tremor is not associated with cerebellar Purkinje cell lossMov Disord20142949650010.1002/mds.2584524532134
    Back to article
  64. 64
    DeuschlGElbleREssential tremor: Neurodegenerative or nondegenerative disease towards a working definition of ETMov Disord2009142033204110.1002/mds.2275519750493
    Back to article
  65. 65
    RajputAHAdlerCHShillHARajputAEssential tremor is not a neurodegenerative diseaseNeurodegener Dis Manag2012225926810.2217/nmt.12.2323105950
    Back to article
  66. 66
    JellingerKAIs there cerebellar pathology in essential tremor?Mov Disord20142943543610.1002/mds.2585224585416
    Back to article
DOI: https://doi.org/10.5334/tohm.229 | Journal eISSN: 2160-8288
Journal RSS Feed
Language: English
Submitted on: May 21, 2014
Accepted on: Jun 16, 2014
Published on: Jul 16, 2014
Published by: Columbia University Libraries/Information Services
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
essential tremor,
GABA,
gamma-aminobutyric acid

© 2014 Alexandre Gironell, published by Columbia University Libraries/Information Services
This work is licensed under the Creative Commons License.

Previous articleVolume 4 (2014): Issue 0Next article